Female laboratory worker inspecting a vial.

$3 million for blood cancer research

Beyond the technical terminology of leukemias, myelomas, lymphomas, myelodysplastic syndromes, and myeloproliferative neoplasms, lies a far more striking reality: more than 155,000 Canadians are grappling with diverse forms of blood cancers. These cancers strike unpredictably, impacting children, young adults, and the elderly alike.

In response to this reality, the Cancer Research Society (CRS) and the Leukemia and Lymphoma Society of Canada (LLSC) are jointly announcing an exceptional partnership, amounting to $3 million, dedicated to research on blood cancers.